Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer

MLA

John M. Mariadason, et al. Promoter Hypomethylation of NY-ESO-1, Association with Clinicopathological Features and PD-L1 Expression in Non-Small Cell Lung Cancer. Jan. 2023. EBSCOhost, https://doi.org/10.26181/22565083.

APA

John M. Mariadason, Paul C. Boutros, Gavin M. Wright, Mun Sem Liew, Thomas John, Aparna Jayachandran, Anderly C. Chueh, Maud H.W. Starmans, Stephen Barnett, Prudence A. Russell, & Marzena Walkiewicz. (2023). Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer. https://doi.org/10.26181/22565083

Chicago

John M. Mariadason, Paul C. Boutros, Gavin M. Wright, Mun Sem Liew, Thomas John, Aparna Jayachandran, Anderly C. Chueh, et al. 2023. “Promoter Hypomethylation of NY-ESO-1, Association with Clinicopathological Features and PD-L1 Expression in Non-Small Cell Lung Cancer,” January. doi:10.26181/22565083.